NIIMBL National Meeting Recap
June 23, 2017
More than 250 representatives turned out in Washington D.C. last month for the inaugural NIIMBL National Meeting. The two-day event brought together stakeholders from industry, academia, non—profit, state and local governments, and federal agencies to network and collaborate in anticipation of NIIMBL’s quick start project call this summer.
In addition to networking opportunities, the first day of the event featured a distinguished lineup of speakers including Senator Chris Coons, Congressman Tom Reed, Acting NIST Director and Acting Under Secretary of Commerce for Standards and Technology Kent Rochford, FDA CDER Director Janet Woodcock, FDA CBER Director Peter Marks, and Biotechnology Innovation Organization (BIO) CEO Jim Greenwood.
Speakers addressed the impact NIIMBL will have on biopharmaceutical manufacturing technology, public health and U.S. economic development.
Also, representatives from leading biomanufacturers lent their thoughts on challenges and opportunities facing the industry during plenary presentations and an engaging Industry Roundtable discussion.
The afternoon featured the SME Innovation Showcase, where small-to-medium enterprises (SMEs) gave a rapid-fire two-minute pitch on their company’s technology and capabilities.
The members-only second day featured the first gatherings of the NIIMBL Governing Committee (GC) as well as Technical Activities Committee (TAC), Workforce Activities Committee (WAC), and Regulatory Coordinating Committee (RCC). Members provided tremendous insight and input into the direction each of these committees will take as they work to realize the NIIMBL mission.
A sincere thank you to all attendees who made the first NIIMBL National Meeting a success.
Initial planning has already begun for the next NIIMBL National Meeting. We anticipate the event will take place in late 2017. If your organization is interested in hosting the next National Meeting, please contact us at email@example.com.